Target intelligence / Profile preview

Ankyrin repeat domain 20 family member A4, pseudogene (ANKRD20A4P)

Target
ANKRD20A4P
Molecular classification
Pseudogene, Other
01

Overview

ANKRD20A4P (Ankyrin repeat domain 20 family member A4, pseudogene) is a pseudogene locus in the human genome and is classified as a non-protein-coding genetic element[2]. It shares sequence similarity with protein-coding ankyrin repeat domain genes but contains mutations or deletions that prevent translation into a functional ankyrin-repeat-containing protein[2]. Pseudogenes like ANKRD20A4P may act as regulatory RNAs by competing for microRNA binding and, in rare cases for some pseudogenes, may influence the expression of their parental genes or participate in long non-coding RNA functions[5][3]. However, there is no experimental evidence that ANKRD20A4P produces a protein or has a documented healthy or disease-promoting biological function, nor is it recognized as a drug target or therapeutic receptor[2][1]. The gene is listed in major databases such as NCBI Gene (728747) and Ensembl (ENSG00000172014), but designated as a pseudogene without known clinical relevance[2][1].

Other names
ANKRD20A4Ankyrin repeat domain-containing protein 20A4 pseudogenePutative ankyrin repeat domain-containing protein 20A4OTTHUMG00000066855Ankyrin repeat domain 20 family, member A4Ankyrin repeat domain-containing protein 20A4
02

Biological functions

Competes for microRNA binding (putative role for expressed pseudogenes in general, not specific evidence for ANKRD20A4P)
03

Disease associations

Other (no evidence of direct disease association or causation)

Beyond the preview

Go deeper on Ankyrin repeat domain 20 family member A4, pseudogene (ANKRD20A4P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain 20 family member A4, pseudogene (ANKRD20A4P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call